Riskpilot← Back to searchSign inGet full accessHarfouche Medical AB
ABActiveOrg 5593507469Brunnsvägen 27General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2025
SEK 27K
+400% vs 2024
EBITDA margin
89.3%
+488% vs 2024
Equity ratio
75.9%
Financial strength
Net profit 2025
SEK 19K
+335% vs 2024
| Revenue | SEK 27K | +400% |
| EBITDA | SEK 24K | +488% |
| Net profit | SEK 19K | +335% |
| Total assets | SEK 59K | +122% |
| Equity | SEK 44K | +78% |
| Employees | 0 | — |
Legal name
Harfouche Medical AB
Org number
5593507469
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva sjuk-, skönhets-, och digital vård inom primär- och sluten vården och angränsande områden. Detta inkluderar medicinska konsulttjänster, uthyrning av personal till primärvård och sjukhus samt därmed förenlig verksamhet i Sverige och utomlands. Aktiebolaget ska äga och handla mark och fastigheter och bedriva konsultation inom försäljning, uthyrning och förvaltning av fastigheter samt därmed förenlig verksamhet i Sverige och utomlands.
Address
Brunnsvägen 27
Email
harfouche.medical@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 5 | 27 |
| Staff expenses | — | — | — | — |
| EBITDA | −1 | −3 | 4 | 24 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −1 | −3 | 4 | 24 |
| Net financials | −0 | 0 | 0 | 0 |
| Profit before tax | −1 | −3 | 4 | 24 |
| Tax | — | — | — | −5 |
| Net profit | −1 | −3 | 4 | 19 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 24 | 21 | 26 | 59 |
| Equity | 24 | 21 | 25 | 44 |
| Long-term debt | — | — | — | — |
| Short-term debt | — | — | 1 | 14 |
| Total debt | — | — | 1 | 14 |
EBITDA margin
89.3%
This company
15.8%
Market median
+465% vs market
20222025
Equity ratio
75.9%
This company
38.2%
Market median
+99% vs market
20222025
Return on equity
43.7%
This company
18.4%
Market median
+138% vs market
20222025
Net profit margin
72.0%
This company
8.1%
Market median
+789% vs market
20222025
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20222025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-03 – 2022-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Harfouche Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stephanie Pamela Harfouche | Board of Directors | 0 companies |
| Peter Elie Harfouche | Board of Directors | 0 companies |